newsfilter
← Latest News
PR Newswire·

Citius Oncology Announces Pricing of $9.0 Million Public Offering

Citius Oncology, Inc. ("Citius Oncology" or the "Company") (Nasdaq: CTOR), a majority-owned subsidiary of Citius Pharmaceuticals, Inc. (Nasdaq:...